Direct to consumer lab testing lets a patient pick a lab test from an online catalog, pay for it at checkout, have a licensed provider authorize the order, give a sample at a Quest or Labcorp draw site, at home with a capillary kit, or through a mobile phlebotomist, and get results back in a patient portal with a clinician's review attached. No insurance claim is filed and no prior doctor visit is required. As of September 2026 it is a standard feature of telehealth storefronts in weight loss, hormone therapy, and longevity.
The word founders misread is "direct." In most of the US, a patient cannot hand a clinical laboratory a testosterone panel request with no clinician involved. Federal CLIA rules require a test request from an "authorized person," and state law decides who that is. So every serious direct to consumer lab testing program has a licensed provider signing the order, which is why an infrastructure partner with a provider network can run the whole flow under a brand's name.
This guide covers the mechanics, the law, typical panels, result review, and how to add a lab catalog to a storefront. This is general information, not legal or medical advice.
Key takeaways
- Direct to consumer lab testing means the patient selects and pays for a test online, a licensed provider authorizes the order, the sample is collected at a draw site, at home, or by a mobile phlebotomist, and a clinician reviews the results before they are released.
- Under CLIA, a laboratory needs a test request from an "authorized person," and state law defines who that is; the practical industry standard is to have a licensed provider authorize every order regardless of the patient's state.
- Quest's and Labcorp's own consumer storefronts route orders through independent physician networks, so provider authorization is the mainstream design, not a workaround.
- The three collection paths (walk-in draw site, at-home capillary kit, mobile phlebotomy) trade panel breadth against convenience, and most brands offer at least two.
- A lab catalog on a telehealth storefront is both an acquisition channel and a clinical feedback loop, but only when results are read back into the treatment plan instead of parked in a PDF.
What is direct to consumer lab testing?
Direct to consumer (DTC) lab testing, also called direct access testing or consumer-initiated testing, is any model in which the patient, not a treating physician, starts the lab order. The patient picks a test from a menu, pays a listed price, and arranges collection. The assays are ordinary clinical tests run by CLIA-certified laboratories; what changes is who initiates the order and who pays.
Three things separate it from the traditional flow:
- Cash pay. The patient pays at checkout; nothing is billed to a health plan.
- Catalog selection. The patient picks a curated panel instead of receiving a requisition after a visit.
- Provider authorization built in. A licensed clinician signs the order and, in a well-run program, reviews the results, with no prior relationship required.
Someone searching to order lab tests online, to order your own lab tests, or for an at home blood test is describing the same service with a different collection preference.
How does direct to consumer lab testing work step by step?
Step 1: The patient orders from a catalog. The storefront lists tests with plain-language descriptions and prices. The patient completes a short intake (identity, date of birth, state of residence, sometimes symptom questions) and pays.
Step 2: A licensed provider signs the order. A clinician licensed in the patient's state reviews the request and issues the requisition. On questhealth.com, Quest's consumer site, a physician from PWNHealth, an independent network, reviews each purchase and places the order; Labcorp OnDemand states that all of its testing requires an order from an authorized healthcare professional supplied by contracted independent providers. In a MyOrbitHealth-powered brand, a Provider Network clinician handles this step inside OrbitOS, so the order lives on the patient's chart from the start.
Step 3: The sample is collected. The patient chooses one of three paths, covered in the next section.
Step 4: The lab runs the test. A CLIA-certified laboratory processes the sample, typically within days for routine chemistry and longer for specialty assays.
Step 5: Results are reviewed and released. The ordering provider reviews the values, flags anything critical, and releases the report. In a treatment program the result then changes something: a dose, a follow-up date, a referral. Federal rules since 2014 also give patients the right to obtain completed reports directly from a HIPAA-covered laboratory, so a brand cannot hold results behind a paid visit.
What are the three ways a sample can be collected?
Collection is where patient experience and clinical scope diverge. Orbit Labs supports all three.
| Collection method | How it works | Best for | Trade-offs |
|---|---|---|---|
| Walk-in draw site (Quest or Labcorp order slip) | Patient receives a requisition and visits any patient service center for a venous draw | Full panels, fasting tests, anything needing serum volume | Requires travel and usually an appointment; site density varies by region |
| At-home capillary kit (Tasso, shipped via FedEx) | Kit ships to the patient; an FDA-cleared device draws capillary blood from the upper arm; sample returns by prepaid courier | Monitoring panels and markers validated for capillary samples; patients far from a draw site | Smaller sample volume limits the assay menu; patient must collect correctly |
| Mobile phlebotomy | A phlebotomist visits the patient's home or office for a venous draw and transports the sample | Full panels with zero travel; concierge programs; homebound patients | Highest per-collection cost; coverage thins outside metro areas |
The at-home kit drives most consumer demand. Tasso's Tasso+ device received FDA 510(k) Class II clearance in September 2022 for self-collection of capillary blood. It does not replace a venous draw for every test, so a catalog should mark which panels are kit-eligible.
Mobile phlebotomy has gone mainstream as well: Quest launched its own in-home service, Quest Mobile, in November 2023, and independent networks cover most metro areas. We cover when it beats a draw site in our guide to mobile phlebotomy for telehealth brands.
What does the law require for direct to consumer lab testing?
Two layers matter: federal CLIA rules and state law. This is general information as of September 2026, not legal advice; check your launch states with counsel.
Federal (CLIA). Under 42 CFR 493.1241, a laboratory must have a written or electronic test request from an "authorized person," defined as an individual authorized under state law to order tests or receive results. CLIA itself does not ban direct access testing; it defers to the states on who may order. That is why the answer to "can I order my own lab tests" depends on where the patient lives.
State law. States fall into three rough groups:
- Broad direct access. Arizona is the best-known example. Its 2015 law (A.R.S. 36-468) lets residents order any test from a licensed clinical laboratory without a provider order, with the results going straight to the patient.
- Partial direct access. Many states let consumers order some tests directly, often a defined list, while requiring a provider order for the rest. New York, for instance, permits direct access only for tests that have an FDA-approved over-the-counter kit or collection device, and only through labs holding a New York State clinical laboratory permit; everything else needs a practitioner order.
- Provider order required. A few states are cited by industry sources as requiring a practitioner order for most or all clinical testing. Lists vary by source and change over time, so treat any state count as a starting point, not a compliance answer.
The practical conclusion. Because state rules vary and the lab still needs an authorized requisition, essentially every national consumer lab program has a licensed provider authorize every order in every state. That satisfies CLIA and the strict states, and puts a clinician in the loop for result review.
For a telehealth brand, that makes a lab catalog a clinical service, not an e-commerce SKU. The signing provider must be licensed in the patient's state, credentialed, and working under an arrangement that respects corporate practice of medicine rules, the same structure that governs prescribing. Our MSO model and telehealth compliance guide explains how non-clinician founders set that up.
Patient access to results. Under the 2014 CLIA and HIPAA amendments, effective October 2014, HIPAA-covered laboratories must give patients their completed test reports on request, generally within 30 days, and the rule preempts state laws that restricted that access. Design your results workflow assuming the patient will see every value.
Privacy. Lab results are protected health information, so the brand needs a business associate agreement with every vendor that touches them.
What lab panels do telehealth brands typically sell?
The catalog should match the verticals the brand treats. Common groupings:
| Program | Typical baseline panel | Typical monitoring cadence |
|---|---|---|
| GLP-1 weight loss | Comprehensive metabolic panel, lipid panel, HbA1c, TSH, sometimes lipase and a pregnancy test | Baseline, then periodic per provider protocol |
| TRT and men's health | Total and free testosterone, estradiol, CBC (hematocrit), PSA, CMP, LH/FSH | Baseline, early follow-up after dose start, then periodic |
| Women's hormone and menopause | FSH, estradiol, TSH, CBC, lipid panel, sometimes progesterone and DHEA-S | Baseline plus symptom-driven follow-up |
| Longevity and wellness | CMP, CBC, lipid panel, HbA1c, hs-CRP, vitamin D, ferritin, thyroid panel | Annual or semi-annual |
Which markers belong in a panel is a clinical decision for the brand's medical leadership; the rows above are illustrative, not a protocol. The founder decides the catalog structure: which panels sell standalone, which are bundled into a subscription, and which collection methods each supports.
The catalog is also a front door. A patient who buys a standalone hormone panel and gets a result that warrants treatment is a warm lead for the brand's TRT or menopause program, with baseline labs already on the chart.
How should direct to consumer lab results be reviewed?
A PDF with reference ranges emailed to the patient is the weakest version of this product. A well-designed program does four things:
- Provider review before release. The ordering provider reviews every result; critical values trigger same-day outreach.
- Plain-language interpretation. Each marker is explained in the portal in words a non-clinician understands, noting that reference ranges vary by lab.
- Results read into the plan. In a treatment program the result should change something: a dose, a follow-up date, a referral, or a decision not to treat. Orbit Labs writes results to the encounter in OrbitOS so the provider sees them next to the intake and prescription history, not in a separate inbox.
- A clear next step. The patient always knows what happens next: a message, a follow-up, or a referral for anything outside the brand's scope.
Standalone consumer tests carry a specific risk: a patient sees an abnormal value with no context and no one to ask. Offer a results consultation, asynchronous or a short video visit, with every catalog purchase.
How do telehealth brands add a lab catalog to their storefront?
Building it from scratch means contracting with Quest and Labcorp (or an aggregator), integrating requisition and result feeds, sourcing at-home kits and courier logistics, contracting mobile phlebotomy coverage, and standing up a provider group licensed in every state you sell into. For a small team that is a multi-quarter project, on top of everything else in our telehealth startup cost breakdown.
The alternative is a white-label telehealth platform with the lab layer already built. On MyOrbitHealth, Orbit Labs works like this:
- Catalog on the brand's storefront. A patient self-order lab catalog under the brand's own domain, on the same storefront, checkout, and subscription engine as the rest of the clinic. The brand sets prices and is the merchant of record.
- Provider authorization from the network. Every order is authorized by a licensed clinician from the Provider Network of 2,400+ board-certified providers covering all 50 states, credentialed to NCQA standards with monthly OIG and SAM screening. The same provider reviews the result.
- Three collection paths. Walk-in Quest or Labcorp order slip, Tasso at-home kit shipped via FedEx, or mobile phlebotomy, selectable per test and per patient.
- Results into the chart. Results land on the patient's record in OrbitOS and are read into the treatment plan, so the prescribing provider can adjust without switching systems.
- Developer access. Brands running their own front end drive the same lab flow through the REST API, webhooks, and React SDK.
- Compliance and terms. HIPAA with a BAA in every contract, SOC 2 Type II, and HITRUST-aligned architecture; testing runs in CLIA-certified laboratories. Pricing is a flat scoped platform fee, no revenue share, no exit fee, and the brand owns its patients and data.
Details are on the Orbit Labs page.
Build versus partner is the same decision founders face for prescribing and pharmacy, and our white-label telehealth platform guide frames it. As of September 2026, many white-label platforms still treat labs as a third-party integration, so ask any vendor specifically about catalog, provider authorization, collection options, turnaround, and result routing before you sign.
Frequently asked questions
Can a patient order lab tests without a doctor?
It depends on the state. Arizona lets consumers order any test directly from a licensed lab; New York limits direct access to tests with FDA-approved over-the-counter kits; other states sit in between. Because CLIA requires a requisition from an authorized person and state rules vary, nearly every national consumer lab program has a licensed provider authorize each order regardless of where the patient lives.
How accurate are at-home blood tests?
Kits like Tasso collect capillary blood that is analyzed by the same CLIA-certified laboratories that process venous samples, and the Tasso+ device is FDA-cleared for collection. Accuracy depends on the assay being validated for capillary samples and on correct collection by the patient, which is why not every test is offered in kit form.
Does insurance cover direct to consumer lab tests?
Generally no. The model is cash pay by design: the patient pays the listed price at checkout, and nothing is billed to a health plan. Some patients use HSA or FSA funds, but a brand should confirm eligibility rules with a benefits adviser rather than promise it.
Who reviews the results of a consumer-ordered lab test?
The licensed provider who authorized the order reviews the results, flags critical values, and releases the report to the patient. Under the 2014 CLIA and HIPAA amendments, patients also have the right to request completed reports directly from the laboratory, so results cannot be withheld.
How does a telehealth brand add lab testing to its storefront?
Either by contracting labs, kit vendors, phlebotomy networks, and a provider group directly, or by using a white-label telehealth platform with a native lab layer. On MyOrbitHealth, Orbit Labs puts a self-order catalog on the brand's storefront, has a network provider authorize each order, supports draw-site, at-home kit, and mobile phlebotomy collection, and writes results into the patient's chart.
Add a lab catalog to your clinic
Orbit Labs gives a branded telehealth storefront a self-order lab catalog, provider-authorized orders from 2,400+ board-certified providers across all 50 states, three collection paths, and results that flow into the treatment plan. Book a demo to see the catalog and collection map for your launch states.